INSPIRED THINKING GROUP (ITG) LIMITED

Company number 02967284 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: INSPIRED THINKING GROUP (ITG) LIMITED

Financial Health Score

Grade: C — Administratively Compliant, Financially Unassessed

This grade reflects the company’s regulatory standing and structural profile only. A full financial health grade requires turnover, profit, asset, liability, and cash flow figures, which were not included in the data provided. Based on available indicators, the company is active and up to date with filings, but its underlying financial performance cannot be verified from the information supplied.

Key Vital Signs

Indicator Reading Interpretation
Company status Active The company is registered and trading; no insolvency proceedings such as liquidation, administration, or receivership are recorded.
Filing compliance Up to date Both annual accounts and confirmation statement are current; no overdue status is indicated.
Company age Incorporated 13 September 1994 Approximately 31 years of continuous registration, suggesting an established trading history.
Share capital £3.00 Nominal capital only; indicates a very thin disclosed equity cushion at formation.
Ownership Multiple corporate entities with significant influence or control Suggests a group structure with parent or holding companies; financial strength may sit outside this individual entity.
Financial statements Not provided No turnover, profit, balance sheet, or cash flow data available for ratio analysis.

Symptoms Analysis

The available data shows no immediate signs of regulatory distress: the company is not in liquidation, administration, or receivership, and its filings are not overdue. However, several features warrant closer examination:

  • Minimal disclosed equity: A share capital of £3 is nominal. In medical terms, this is like a patient with very low body reserves; it offers little buffer against unexpected shocks, though it does not necessarily reflect current net worth if profits have been retained over time.
  • Group ownership: Several corporate entities hold significant influence or control, including rights to appoint and remove directors. This can mean access to group resources, but it also means this company’s decisions and financial health may be dependent on parents outside this dataset.
  • Missing clinical data: Without the profit and loss account, balance sheet, and cash flow statement, it is impossible to diagnose profitability, liquidity (ability to pay bills as they fall due), or solvency (whether assets exceed liabilities).

Diagnosis

Based on the information provided, the company presents as administratively stable but financially opaque. There is no evidence of insolvency or filing distress. The primary “symptom” is a lack of visible financial substance in the data supplied: the £3 share capital and layered corporate ownership suggest a structure that may be supported by external group funding, but the standalone financial strength of this entity cannot be confirmed.

Prognosis

The outlook is guarded pending review of the full statutory accounts. If the accounts for the year ended 31 December 2025 show consistent profitability, positive net assets, and healthy cash reserves, the prognosis is favourable. If they reveal losses, negative net assets, or deteriorating liquidity, the company may face pressure despite its clean filing record. Continued compliance with filing deadlines will be important to avoid regulatory penalties.

Recommendations

  1. Obtain the full statutory accounts for the year ended 31 December 2025, including the balance sheet, profit and loss account, and directors’ report.
  2. Calculate core ratios once figures are available: current ratio (current assets divided by current liabilities) to test short-term liquidity; net asset position to assess solvency; and profit margins to gauge profitability.
  3. Review the group structure to understand whether this company relies on funding or guarantees from parent entities, and whether any cross-guarantees or intercompany debts exist.
  4. Monitor filing deadlines to maintain the current clean compliance record and avoid late filing penalties.
  5. Assess working capital to ensure the company can meet obligations as they fall due over the next 12 months.

Perspective: Financial Health Diagnostician · Model: nvidia/nemotron-3.5-super-vl:free · Generated 9 November 2026